Evidence map›Paper›PMID 31775680›Full record

ArticleBMC cancer2019

Clinical and imaging features of myeloid sarcoma: a German multicenter study.

Hans-Jonas Meyer, Wolfram Pönisch, Stefan Andreas Schmidt, Susanne Wienbeck, Friederike Braulke, Dominik Schramm, Alexey Surov

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Diagnosing Myeloid Sarcoma from Peritoneal FluidTurkish journal of haematology : official journal of Turkish Society of Haematology · 2025
    Article
  8. Article
  9. Diagnostic Approaches in Myeloid Sarcoma.Current issues in molecular biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Leukaemic Ascites and Peritoneal Myeloid Sarcoma: Rare but Not Impossible.European journal of case reports in internal medicine · 2022
    Article
  16. Case report: AFrontiers in oncology · 2022
    Article
  17. Article
  18. Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience.Mediterranean journal of hematology and infectious diseases · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hans-Jonas MeyerDepartment of Diagnostic and Interventional Radiology, University of Leipzig, University Hospital Leipzig, Liebigstraße 20, 04103, Leipzig, Germany. Hans-jonas.meyer@medizin.uni-leipzig.de.ORCID http://orcid.org/0000-0001-8489-706X
Wolfram PönischDepartment of Hematology and Oncology, University Hospital Leipzig, Leipzig, Germany.
Stefan Andreas SchmidtDepartment of Diagnostic and Interventional Radiology, Ulm University Medical Center, 89081, Ulm, Germany.
Susanne WienbeckDepartment of Diagnostic and Interventional Radiology, University Medicine Göttingen, 37075, Göttingen, Germany.
Friederike BraulkeDepartment of Hematology and Medical Oncology, University Medicine Göttingen, 37075, Göttingen, Germany.
Dominik SchrammDepartment of Diagnostic and Interventional Radiology, University Hospital of Halle (Saale), 06097, Halle (Saale), Germany.
Alexey SurovDepartment of Diagnostic and Interventional Radiology, University of Leipzig, University Hospital Leipzig, Liebigstraße 20, 04103, Leipzig, Germany.
University Hospital Leipzig · DEUniversitätsmedizin Göttingen · DEUniversität Ulm · DEUniversity Hospital in Halle · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyeloid sarcoma (MS), also known as chloroma, is an extramedullary manifestation of malignant primitive myeloid cells. Previously, only small studies investigated clinical and imaging features of MS. The purpose of this study was to elucidate clinical and imaging features of MS based upon a multicenter patient sample.

methodsPatient records of radiological databases of 4 German university hospitals were retrospectively screened for MS in the time period 01/2001 and 06/2019. Overall, 151 cases/76 females (50.3%) with a mean age of 55.5 ± 15.1 years and 183 histopathological confirmation or clinically suspicious lesions of MS were included into this study. The underlying hematological disease, localizations, and clinical symptoms as well as imaging features on CT and MRI were investigated.

resultsIn 15 patients (9.9% of all 151 cases) the manifestation of MS preceded the systemic hematological disease. In 43 cases (28.4%), first presentation of MS occurred simultaneously with the initial diagnosis of leukemia, and 92 (60.9%) patients presented MS after the initial diagnosis. In 37 patients (24.5%), the diagnosis was made incidentally by imaging. Clinically, cutaneous lesions were detected in 35 of 151 cases (23.2%). Other leading symptoms were pain (n = 28/151, 18.5%), neurological deficit (n = 27/151, 17.9%), swelling (n = 14/151, 9.3%) and dysfunction of the affected organ (n = 10/151, 6.0%). Most commonly, skin was affected (n = 30/151, 16.6%), followed by bone (n = 29/151, 16.0%) and lymphatic tissue (n = 21/151, 11.4%). Other localizations were rare. On CT, most lesions were homogenous. On T2-weighted imaging, most of the lesions were hyperintense. On T1-weighted images, MS was hypointense in n = 22/54 (40.7%) and isointense in n = 30/54 (55.6%). A diffusion restriction was identified in most cases with a mean ADC value of 0.76 ± 0.19 × 10

conclusionsThe present study shows clinical and imaging features of MS based upon a large patient sample in a multicenter design. MS occurs in most cases meta-chronous to the hematological disease and most commonly affects the cutis. One fourth of cases were identified incidentally on imaging, which needs awareness of the radiologists for possible diagnosis of MS.

Indexed as

AdultAgedDiagnostic ImagingFemaleGermanyHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesSarcoma, MyeloidSymptom AssessmentTomography, X-Ray ComputedAcute myeloid leukemiaChloromaGranulocytic sarcomaMyeloid sarcoma

Identifiers

PMID31775680
PMCPMC6882227
OpenAlexW2990802915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.